Abbott | ABT - Net Income

Stock Price
108.64
Daily Change
0.44 0.41%
Monthly
-14.08%
Yearly
-17.73%
Q1 Forecast
105.93

Abbott reported $1.78B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Agilent USD 434M 98M Sep/2025
AtriCure USD -267K 5.92M Sep/2025
Baxter International USD -46M 137M Sep/2025
Becton, Dickinson and Co. USD 493M 81M Sep/2025
Bio-Rad Laboratories USD 317.8M 253.8M Jun/2025
Boston Scientific USD 672M 83M Dec/2025
Cooper Companies USD 84.6M 13.7M Sep/2025
Danaher USD 1.2B 289M Dec/2025
Dexcom USD 179.8M 74.4M Jun/2025
Edwards Lifesciences USD 291.1M 42.1M Sep/2025
Globus Medical USD 118.97M 83.88M Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
Insulet USD 87.6M 65.1M Sep/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
J&J USD 5.12B 36M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.37B 334M Sep/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Smith & Nephew USD 293M 79M Dec/2025
Solventum Corp USD 1.27B 1.18B Sep/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -21.16M 31.24M Sep/2025
Teleflex USD -408.89M 531.47M Sep/2025
Terumo JPY 35.05B 6.79B Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Zimmer Biomet Holdings USD 230.9M 78.1M Sep/2025